Search for: "Pfizer Inc. v. Government of India"
Results 21 - 36
of 36
Sorted by Relevance
|
Sort by Date
22 Feb 2008, 1:30 pm
The decision in Reidel v. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by EPO:… [read post]
8 Dec 2007, 11:00 am
(more on the Wahaha v Danone dispute): (China Business Law Blog), What Global Players could learn from Wii v Vii [Nintendo's global new product launch mistakes]: (IPDragon), (China Law Blog), Junk Patents: (China Hearsay),Has your distributor (representative, manufacturer) in China registered your mark? [read post]
20 Jun 2008, 8:07 am
– Comments on IPEG post on Zyprexa patent case: (BLOG@IP::JUR) India takes open source approach to drug discovery: (Patent Lens), India: Is the Indian Drug Controller participating in the ACTA negotiations? [read post]
5 Sep 2008, 11:01 pm
’s yodel first sound mark granted by India’s trade mark regis [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
7 Mar 2008, 2:00 am
You’ve just lost some IP: (Securing Innovation), Competition – Film your IP issue: (WIPO), First WIPO Committee on Development and Intellectual Property (CDIP) meeting begins: (Intellectual Property Watch), (KEI Policy Blogs), (KEI Policy Blogs), (WIPO), One internet, two modes of governance: (IP Justice), Business, governments see momentum for global anti-counterfeiting treaty but EU snags: (Intellectual Property Watch), Intergovernmental… [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in… [read post]
10 Jan 2022, 4:01 pm
The incident followed the publication of a peer-review article that questioned the integrity and regulatory oversight issues surrounding Pfizer’s phase III Covid-19 vaccine trial. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will address… [read post]
1 Feb 2008, 12:00 am
: Industries Ltd v Dynamic Supply Pty Ltd: (IP Down Under)BrazilIFPI raids hundreds of internet cafes: 600 cops, one arrest: (Ars Technica)CanadaInterlocutory injunctions in trade mark cases: a difficult test to meet: CMAC Mortgages v Canadian Mortgage Expert Centre and CanadaHyundai Autov Cross Canada Auto Body Supply: (Canadian Trademark Blog), (coverage of Hyundia - IPblog), Privacy Coalition warns on copyright reform: (Michael Geist),Wikinomics on… [read post]
13 Jul 2021, 10:58 am
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
